1. Home
  2. TRDA vs KALV Comparison

TRDA vs KALV Comparison

Compare TRDA & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRDA
  • KALV
  • Stock Information
  • Founded
  • TRDA 2016
  • KALV N/A
  • Country
  • TRDA United States
  • KALV United States
  • Employees
  • TRDA N/A
  • KALV N/A
  • Industry
  • TRDA Biotechnology: Pharmaceutical Preparations
  • KALV Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRDA Health Care
  • KALV Health Care
  • Exchange
  • TRDA Nasdaq
  • KALV Nasdaq
  • Market Cap
  • TRDA 336.6M
  • KALV N/A
  • IPO Year
  • TRDA 2021
  • KALV N/A
  • Fundamental
  • Price
  • TRDA $8.38
  • KALV $11.90
  • Analyst Decision
  • TRDA Strong Buy
  • KALV Strong Buy
  • Analyst Count
  • TRDA 3
  • KALV 8
  • Target Price
  • TRDA $25.67
  • KALV $24.83
  • AVG Volume (30 Days)
  • TRDA 139.5K
  • KALV 506.1K
  • Earning Date
  • TRDA 05-08-2025
  • KALV 03-12-2025
  • Dividend Yield
  • TRDA N/A
  • KALV N/A
  • EPS Growth
  • TRDA N/A
  • KALV N/A
  • EPS
  • TRDA 0.61
  • KALV N/A
  • Revenue
  • TRDA $172,220,000.00
  • KALV N/A
  • Revenue This Year
  • TRDA N/A
  • KALV N/A
  • Revenue Next Year
  • TRDA N/A
  • KALV N/A
  • P/E Ratio
  • TRDA $14.69
  • KALV N/A
  • Revenue Growth
  • TRDA 5.74
  • KALV N/A
  • 52 Week Low
  • TRDA $7.10
  • KALV $7.30
  • 52 Week High
  • TRDA $21.79
  • KALV $15.50
  • Technical
  • Relative Strength Index (RSI)
  • TRDA 43.04
  • KALV 44.60
  • Support Level
  • TRDA $7.71
  • KALV $11.31
  • Resistance Level
  • TRDA $9.46
  • KALV $13.91
  • Average True Range (ATR)
  • TRDA 0.60
  • KALV 0.68
  • MACD
  • TRDA 0.05
  • KALV -0.14
  • Stochastic Oscillator
  • TRDA 38.29
  • KALV 21.93

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

Share on Social Networks: